Premium
Two antipsychotics fail to improve delirium over placebo in hospital patients
Publication year - 2019
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30393
Subject(s) - delirium , ziprasidone , medicine , haloperidol , placebo , intensive care unit , anesthesia , coma (optics) , intensive care medicine , schizophrenia (object oriented programming) , psychiatry , antipsychotic , alternative medicine , pathology , dopamine , physics , optics
Haloperidol and ziprasidone did not significantly alter the course of delirium compared with placebo in a group of patients with acute respiratory failure or shock in a hospital intensive care unit (ICU), a study has found. Researchers had hypothesized that both the typical and atypical antipsychotics would result in a shorter duration of delirium and coma than placebo.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom